NewLead needs money, no one would lend the money to them, but IronRidge said yes, this is how works, first they agreed the conversion price, said 20% discount for the lowerest price over last 5 days,
Let us say, at the beginning, stock price is $1, they need to convert $100 per day, day 1, they will request 120 shares and give 100 to the company
Day2, stock at 0.5, they will request 240 from the company and give 100 to the company
Day3, stock at 0.05 they will request 2400 shares from the company and give the 100 to the company,
So in this case, in three days, company received $300 and issue almost 3000 shares .
Days 30, stock at 0.00005, the company received 100 and issued 2400000 shares to the company, so really the stock price in the past is irrlevent in this case, since more shares issued at lower stock price.
Stay away from this scam.
Like New Market Technology, At one time, the stock went down from $2 to 0.001 within 6 months, their conversion price is based on the 10% below the average price for last 10 days. If you are a trade, you have far more better opportunities then these scam artists(company's management).
no set conversion price, you should avoid the stock all together. for the debt holder, they don't care the stock price, when the stock went down the company will issue them more shares. Most important, the company does not care what the conversion price, why should you?
In the past, I watched couple of these stocks, like NMKT, CCRC?(no longer exist), most of these stocks are down over 99% every year, how can you beat them, unless you find the way to short(unfortunatley, most shop will not allow you to short these kind of stocks.)
Agree. No need for dividend increase at this time, Peers is trading below 4% right now. IRT should make around 0.20 for this quarter, so the fair value should be around 13-14 based on the current earning/dividend yield. It appeared not much of selling pressure right now.
I think the results is not that bad.
1) DCVAX-L interim data was not released, by law, the company had to release the data if they receive it. Unless you think the company break the law by withholding the information. Why the data is not released by DMC, very simple, they did not have enough data. It's been 6 months since the even 66, the longer it takes, the more likely results will be going NWBO's way. Remember, these are mostly deadly brain cancer!
2) DCVAX-D is not effective, this is the quote from Dr. Buzdar, f you flip the coin and the trial results were negative, do you think the company would be disclosing this type of information? No, In other words, they did not dispute the primary results is positive. Folks, we are talking about the cancer that could not be treated in any other way, any positive results will be a big boost for NWBO because this is the only viable treatment option.
IRT is so undervalue compare with others. If no new equity raised, they should be able generate between 0.85-0.90/share from operation on the on going basis. So the dividend could go up toward 0.90 next year, the stock should trade at least 11 if we use the pricing model like others.
Sentiment: Strong Buy
No live cancel cell in the tumor is the same as cancer is cured. We still have not seen this remarkable results been known by the public.
It will certainly give million of cancer patient hope.
Another 2 to 3 cases of complete tumor cell death, that should get European approval, they can pretty much sell the treatment worldwide other then US. best of all, they don't need that much of marketing.
If another report could confirm the drug could kill the cancer cell and enhance the immune cell, they could sell drug in Europe/China, it's only two months away.
I invested stock market over 10 years, and see this happen very often. I once hold the stock I thought should be worth 25, the stock was at around 5 for a long time, finally, I thought I was wrong and sold the position. Sure enough, the stock was up to as high as 80 in the next two years. Wall street overlook something very often. If everything is price perfect, who would invest in the stock market?
You really think the Yahoo message board would have a big influence on the stock price?
in the tumor, for the sake of patient, please stop the phase 2 and 3 trial , give the drug to any patients with this terrible desease. Patients can not waste their time.
Some of the people charge around 100K for the cancer drug that can extend the life on average around 2 months over other treatment, so you can pretty much charge 200K to 300K for one treatment. This is not out of line. The upside could be market value well over 100 billion, if more people's tumor could show the complete tumor death.
that some of the Tumor Cell could be killed completely. They are in the state of shock. Very few people realize this remarkable results, really the break through in cancer treatment, at the same time, given the new, the market cap is still like under 500 million. Shock!